Stifel上调渤健目标价至202美元

Core Viewpoint - Stifel has raised the target price for Boehringer Ingelheim from $144 to $202 and upgraded the rating from "Hold" to "Buy" [1] Group 1 - The target price increase reflects a positive outlook on Boehringer Ingelheim's performance [1] - The upgrade to "Buy" indicates a stronger confidence in the company's future growth potential [1]